Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Watts Ryan J.
President and CEO at Denali Therapeutics. Filing since 29 Aug 2018.
CIK 0001724310
Company
Date
Role
Action
Shares
Amount
Of holding
DNLI
Denali Therapeutics Inc.
6 Jan 2026
President and CEO
Sold at will
35,198
$580.77K
10.6%
DNLI
Denali Therapeutics Inc.
9 Jul 2025
President and CEO
Sold on a plan
495,282
$7.43M
66.2%
DNLI
Denali Therapeutics Inc.
7 Jan 2025
President and CEO
Sold at will
7,650
$159.20K
2.9%
DNLI
Denali Therapeutics Inc.
6 Jan 2025
President and CEO
Sold at will
29,266
$591.76K
10.1%
DNLI
Denali Therapeutics Inc.
18 Oct 2024
President and CEO
Sold on a plan
40,000
$1.11M
14.5%
DNLI
Denali Therapeutics Inc.
20 Aug 2024
President and CEO
Sold at will
2,260
$53.77K
0.9%
DNLI
Denali Therapeutics Inc.
13 Feb 2024
President and CEO
Sold at will
9,589
$165.79K
3.9%
DNLI
Denali Therapeutics Inc.
9 Jan 2024
President and CEO
Sold at will
7,818
$154.64K
0.3%
DNLI
Denali Therapeutics Inc.
5 Jan 2024
President and CEO
Sold at will
17,483
$339.69K
0.8%
DNLI
Denali Therapeutics Inc.
21 Aug 2023
President and CEO
Sold at will
2,309
$52.16K
0.1%
DNLI
Denali Therapeutics Inc.
10 Aug 2023
President and CEO
Sold at will
2,526
$63.23K
0.1%
DNLI
Denali Therapeutics Inc.
16 Jun 2023
President and CEO
Sold at will
50,000
$1.57M
2.2%
DNLI
Denali Therapeutics Inc.
21 Apr 2023
President and CEO
Sold at will
24,800
$623.72K
1.1%
DNLI
Denali Therapeutics Inc.
20 Apr 2023
President and CEO
Sold at will
200
$5.00K
0.0%
DNLI
Denali Therapeutics Inc.
13 Feb 2023
President and CEO
Sold, plan not stated
33,815
$1.02M
1.5%
DNLI
Denali Therapeutics Inc.
10 Feb 2023
President and CEO
Sold, plan not stated
25,000
$727.50K
1.1%
DNLI
Denali Therapeutics Inc.
9 Feb 2023
President and CEO
Sold, plan not stated
3,433
$105.02K
0.2%
DNLI
Denali Therapeutics Inc.
5 Jan 2023
President and CEO
Sold, plan not stated
4,800
$136.51K
0.2%
DNLI
Denali Therapeutics Inc.
4 Jan 2023
President and CEO
Sold, plan not stated
5,029
$144.48K
0.2%
DNLI
Denali Therapeutics Inc.
19 Aug 2022
President and CEO
Sold, plan not stated
2,404
$79.86K
0.1%
DNLI
Denali Therapeutics Inc.
11 Feb 2022
President and CEO
Sold, plan not stated
9,491
$329.53K
0.4%
DNLI
Denali Therapeutics Inc.
9 Feb 2022
President and CEO
Sold, plan not stated
2,719
$102.10K
0.1%
DNLI
Denali Therapeutics Inc.
5 Jan 2022
President and CEO
Sold, plan not stated
5,007
$224.21K
0.2%
DNLI
Denali Therapeutics Inc.
1 Dec 2021
President and CEO
Sold, plan not stated
18,333
$823.58K
0.9%
DNLI
Denali Therapeutics Inc.
1 Nov 2021
President and CEO
Sold, plan not stated
18,333
$912.18K
0.9%
DNLI
Denali Therapeutics Inc.
1 Oct 2021
President and CEO
Sold, plan not stated
18,333
$923.55K
0.8%
DNLI
Denali Therapeutics Inc.
1 Sep 2021
President and CEO
Sold, plan not stated
18,333
$1.00M
0.8%
DNLI
Denali Therapeutics Inc.
19 Aug 2021
President and CEO
Sold, plan not stated
2,376
$117.77K
0.1%
DNLI
Denali Therapeutics Inc.
2 Aug 2021
President and CEO
Sold, plan not stated
18,333
$942.48K
0.8%
DNLI
Denali Therapeutics Inc.
1 Jul 2021
President and CEO
Sold, plan not stated
18,333
$1.42M
0.8%
DNLI
Denali Therapeutics Inc.
1 Jun 2021
President and CEO
Sold, plan not stated
18,333
$1.13M
0.8%
DNLI
Denali Therapeutics Inc.
3 May 2021
President and CEO
Sold, plan not stated
18,333
$1.08M
0.8%
DNLI
Denali Therapeutics Inc.
1 Apr 2021
President and CEO
Sold, plan not stated
18,334
$1.04M
0.8%
DNLI
Denali Therapeutics Inc.
1 Mar 2021
President and CEO
Sold, plan not stated
18,334
$1.22M
0.8%
DNLI
Denali Therapeutics Inc.
11 Feb 2021
President and CEO
Sold, plan not stated
9,473
$665.98K
0.4%
DNLI
Denali Therapeutics Inc.
9 Feb 2021
President and CEO
Sold, plan not stated
5,112
$377.21K
0.2%
DNLI
Denali Therapeutics Inc.
1 Feb 2021
President and CEO
Sold, plan not stated
18,334
$1.25M
0.8%
DNLI
Denali Therapeutics Inc.
4 Jan 2021
President and CEO
Sold, plan not stated
88,334
$6.62M
3.7%
DNLI
Denali Therapeutics Inc.
30 Mar 2020
President and CEO
Sold, plan not stated
4,807
$93.64K
17.9%
DNLI
Denali Therapeutics Inc.
4 Dec 2019
President and CEO
Sold, plan not stated
18,755
$337.59K
0.8%
DNLI
Denali Therapeutics Inc.
3 Dec 2019
President and CEO
Sold, plan not stated
2,513
$45.28K
0.1%
DNLI
Denali Therapeutics Inc.
25 Nov 2019
President and CEO
Sold, plan not stated
42,185
$760.17K
1.7%
DNLI
Denali Therapeutics Inc.
22 Nov 2019
President and CEO
Sold, plan not stated
1,300
$23.40K
0.1%
DNLI
Denali Therapeutics Inc.
5 Sep 2019
President and CEO
Sold, plan not stated
4,847
$87.68K
0.2%
DNLI
Denali Therapeutics Inc.
3 Sep 2019
President and CEO
Sold, plan not stated
3,734
$67.21K
0.1%
DNLI
Denali Therapeutics Inc.
1 Jul 2019
President and CEO
Sold, plan not stated
18,333
$380.59K
0.7%
DNLI
Denali Therapeutics Inc.
3 Jun 2019
President and CEO
Sold, plan not stated
18,333
$349.61K
0.7%
DNLI
Denali Therapeutics Inc.
3 May 2019
President and CEO
Sold, plan not stated
6,111
$149.66K
0.2%
DNLI
Denali Therapeutics Inc.
2 May 2019
President and CEO
Sold, plan not stated
6,111
$146.85K
0.2%
DNLI
Denali Therapeutics Inc.
1 May 2019
President and CEO
Sold, plan not stated
6,112
$147.24K
0.2%
DNLI
Denali Therapeutics Inc.
3 Apr 2019
President and CEO
Sold, plan not stated
6,141
$161.63K
0.2%
DNLI
Denali Therapeutics Inc.
2 Apr 2019
President and CEO
Sold, plan not stated
6,142
$152.51K
0.2%
DNLI
Denali Therapeutics Inc.
1 Apr 2019
President and CEO
Sold, plan not stated
6,050
$144.66K
0.2%
DNLI
Denali Therapeutics Inc.
5 Mar 2019
President and CEO
Sold, plan not stated
6,141
$134.92K
0.2%
DNLI
Denali Therapeutics Inc.
4 Mar 2019
President and CEO
Sold, plan not stated
6,142
$135.96K
0.2%
DNLI
Denali Therapeutics Inc.
1 Mar 2019
President and CEO
Sold, plan not stated
6,050
$135.73K
0.2%
DNLI
Denali Therapeutics Inc.
5 Feb 2019
President and CEO
Sold, plan not stated
8,230
$154.97K
0.3%
DNLI
Denali Therapeutics Inc.
4 Feb 2019
President and CEO
Sold, plan not stated
4,054
$75.50K
0.2%
DNLI
Denali Therapeutics Inc.
1 Feb 2019
President and CEO
Sold, plan not stated
6,050
$112.83K
0.2%
DNLI
Denali Therapeutics Inc.
4 Jan 2019
President and CEO
Sold, plan not stated
6,233
$123.69K
0.2%
DNLI
Denali Therapeutics Inc.
3 Jan 2019
President and CEO
Sold, plan not stated
6,050
$114.28K
0.2%
DNLI
Denali Therapeutics Inc.
2 Jan 2019
President and CEO
Sold, plan not stated
6,050
$118.31K
0.2%
DNLI
Denali Therapeutics Inc.
3 Dec 2018
President and CEO
Sold, plan not stated
18,333
$337.94K
0.7%
DNLI
Denali Therapeutics Inc.
15 Nov 2018
President and CEO
Sold, plan not stated
13,588
$246.24K
0.5%
DNLI
Denali Therapeutics Inc.
13 Nov 2018
President and CEO
Sold, plan not stated
4,746
$85.43K
0.2%
DNLI
Denali Therapeutics Inc.
1 Oct 2018
President and CEO
Sold, plan not stated
18,333
$398.19K
0.7%
DNLI
Denali Therapeutics Inc.
4 Sep 2018
President and CEO
Sold, plan not stated
18,333
$349.43K
0.7%
DNLI
Denali Therapeutics Inc.
29 Aug 2018
President and CEO
Sold, plan not stated
18,334
$330.93K
0.7%
68 decisions on file.
